Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN)

Autor: Igor Chourpa, Stephanie David, Hervé Marchais, Katel Hervé-Aubert, Anne-Sophie Garin, Didier Bedin, Claude Hoinard

Publikováno v: International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2013, 454 (2), pp.660-667. ⟨10.1016/j.ijpharm.2013.05.051⟩

International audience; Short interfering RNAs (siRNAs) can downregulate the synthesis of proteins and thus be used to treat certain diseases where the protein synthesis is upregulated, such as cancer. The challenge is to deliver siRNAs in the target

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ab37d36d7132e72c3cee48fc6f068c
https://doi.org/10.1016/j.ijpharm.2013.05.051